澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

IMUGENE LTD

0.145

+0.0053.57%

成交量：118.76萬

成交額：17.09萬

市值：5,176.58萬

市盈率：-0.63

高：0.145

開：0.140

低：0.140

收：0.140

52周最高：1.122

52周最低：0.135

股本：3.57億

流通股本：2.54億

量比：0.82

換手率：0.47%

股息：- -

股息率：- -

每股收益(TTM):-0.229

每股收益(LYR):-0.316

淨資產收益率：-111.29%

總資產收益率：-39.22%

市淨率：1.24

市盈率(LYR):-0.46

資料載入中...

總覽公司新聞資訊公告

BUZZ-精密生物季度業績超預期後上漲

IMUGENE LTD與JW Therapeutics宣佈開展合作，以推進Oncarlytics與Carteyva®的結合治療實體腫瘤

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IMU.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMU.AU\",,,,,undefined,":{"symbol":"IMU.AU","market":"AU","secType":"STK","nameCN":"IMUGENE LTD","latestPrice":0.145,"timestamp":1774588320000,"preClose":0.14,"halted":0,"volume":1187580,"delay":0,"changeRate":0.035714285714285546,"nameEN":"IMUGENE LTD","floatShares":254199099,"shares":357005792,"eps":-0.228819,"marketStatus":"休市中","change":0.005,"latestTime":"03-27 16:12:00 AEDT","open":0.14,"high":0.145,"low":0.14,"amount":170949,"amplitude":0.035714,"askPrice":0.145,"askSize":178730,"bidPrice":0.14,"bidSize":1057809,"shortable":3,"etf":0,"ttmEps":-0.228819,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.14,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":0.8229572631795391,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMU.AU","preClose":0.14,"auctionPrice":0.145,"auctionVolume":218442,"auction":3,"marketStatus":"盘后竞价","timestamp":1774588209850}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMU.AU\",,,,,undefined,":{"symbol":"IMU.AU","floatShares":254199099,"roa":"-39.22%","roe":"-111.29%","lyrEps":-0.315594,"volumeRatio":0.8229572631795391,"shares":357005792,"dividePrice":0,"high":0.145,"amplitude":0.035714,"preClose":0.14,"low":0.14,"week52Low":0.135,"pbRate":"1.24","psRate":"13.12","week52High":1.122,"institutionHeld":0,"latestPrice":0.145,"committee":0.710919,"eps":-0.228819,"divideRate":0,"volume":1187580,"delay":0,"ttmEps":-0.228819,"open":0.14,"prevYearClose":0.365,"prevWeekClose":0.15,"prevMonthClose":0.24,"prevQuarterClose":0.365,"fiveDayClose":0.15,"twentyDayClose":0.24,"sixtyDayClose":0.365},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMU.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-07-02","symbol":"IMU.AU","type":"split","dateTimestamp":1751378400000,"forFactor":34,"toFactor":1,"ratio":34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMU.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMU.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618513406","title":"BUZZ-精密生物季度業績超預期後上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2618513406","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618513406?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 20:37","pubTimestamp":1773319069,"startTime":"0","endTime":"0","summary":"** 公布第四季度收入为 3420 万美元，超过分析师预期的 910 万美元** 称营收增长主要得益于诺华合作协议中的 2620 万美元和 Imugene 许可协议中的 800 万美元** 2025 年 DTIL 股价上涨超过 9%(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4S4001AE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DTIL","BK7508","BK7067","BK4139","IMU.AU"],"gpt_icon":0},{"id":"1101701814","title":"IMUGENE LTD與JW Therapeutics宣佈開展合作，以推進Oncarlytics與Carteyva®的結合治療實體腫瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1101701814","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101701814?lang=zh_tw&edition=fundamental","pubTime":"2025-11-28 13:01","pubTimestamp":1764306070,"startTime":"0","endTime":"0","summary":"IMUGENE LTD与JW Therapeutics宣布开展合作，以推进Oncarlytics与Carteyva®的结合治疗实体肿瘤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMU.AU","BK7067","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}